RegeneRx Biopharmaceuticals's ticker is RGRX and the CUSIP is 75886X108. A total of 4 filers reported holding RegeneRx Biopharmaceuticals in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $25,000 | -28.6% | 140,000 | -6.7% | 0.00% | 0.0% |
| Q1 2019 | $35,000 | +52.2% | 150,000 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $23,000 | -14.8% | 150,000 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $27,000 | -10.0% | 150,000 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $30,000 | -9.1% | 150,000 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $33,000 | +26.9% | 150,000 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $26,000 | -48.0% | 150,000 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $50,000 | +66.7% | 150,000 | +36.4% | 0.00% | 0.0% |
| Q2 2017 | $30,000 | -6.2% | 110,000 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $32,000 | -8.6% | 110,000 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $35,000 | -14.6% | 110,000 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $41,000 | -19.6% | 110,000 | 0.0% | 0.00% | -50.0% |
| Q2 2016 | $51,000 | – | 110,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DUMONT & BLAKE INVESTMENT ADVISORS LLC | 22,300 | $7,000 | 0.00% |
| Williams Jones Wealth Management, LLC. | 200,000 | $63,000 | 0.00% |